January 11, 2021
December 14, 2022
|By Megan McGregor
Philips also conducted an internal biocompatibility risk assessment, which concluded that degraded foam presents a “significant biological risk to patients.”
Philips also conducted an internal biocompatibility risk assessment, which concluded that degraded foam presents a “significant biological risk to patients.”